Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ketograce Bix is a specialized nutritional supplement developed by Biokindle Lifesciences in the form of oral protein diskettes. It is specifically formulated to address protein deficiency and malnutrition in patients with Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD), and those undergoing dialysis. Each diskette provides 1.6 grams of high-quality protein, primarily composed of casein (over 80%) along with whey and soy proteins, achieving a Protein Digestibility-Corrected Amino Acid Score (PDCAAS) of 1. The product is fortified with essential vitamins and minerals, contains no added sugar, and is suitable for diabetic patients. It serves as a ready-to-eat renal nutrition solution to help maintain protein balance in patients with restricted or compromised kidney function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ketograce Bix.